pubmed-article:14517080 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14517080 | lifeskim:mentions | umls-concept:C0220847 | lld:lifeskim |
pubmed-article:14517080 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
pubmed-article:14517080 | lifeskim:mentions | umls-concept:C0039194 | lld:lifeskim |
pubmed-article:14517080 | lifeskim:mentions | umls-concept:C1516334 | lld:lifeskim |
pubmed-article:14517080 | lifeskim:mentions | umls-concept:C0007586 | lld:lifeskim |
pubmed-article:14517080 | lifeskim:mentions | umls-concept:C0169665 | lld:lifeskim |
pubmed-article:14517080 | lifeskim:mentions | umls-concept:C1704675 | lld:lifeskim |
pubmed-article:14517080 | lifeskim:mentions | umls-concept:C1332737 | lld:lifeskim |
pubmed-article:14517080 | lifeskim:mentions | umls-concept:C1705523 | lld:lifeskim |
pubmed-article:14517080 | lifeskim:mentions | umls-concept:C1412933 | lld:lifeskim |
pubmed-article:14517080 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
pubmed-article:14517080 | lifeskim:mentions | umls-concept:C0444669 | lld:lifeskim |
pubmed-article:14517080 | lifeskim:mentions | umls-concept:C0237477 | lld:lifeskim |
pubmed-article:14517080 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:14517080 | pubmed:dateCreated | 2003-9-30 | lld:pubmed |
pubmed-article:14517080 | pubmed:abstractText | Hepatitis C virus (HCV) is efficient in the establishment of persistent infection. We have previously shown that HCV core protein inhibits T cell proliferation through its interaction with the complement receptor, gC1qR. Here we show that HCV core-induced inhibition of T cell proliferation involves a G(0)/G(1) cell cycle arrest, which is reversible upon addition of anti-gC1qR antibody. Correspondingly, the expression of cyclin-dependent kinases (Cdk) 2/4 and cyclin E/D, as well as subsequent phosphorylation of retinoblastoma (pRb), is reduced in core-treated T cells in response to mitogenic stimulation. Remarkably, degradation of p27(Kip1), a negative regulator of both Cdk4/cyclin D and Cdk2/cyclin E complexes, is significantly diminished in T cells treated with HCV core upon mitogenic stimulation. These data indicate that the stability of p27(Kip1) by HCV core is associated with blocking activated T cells for the G(1) to S phase transition and inhibiting T cell proliferation. | lld:pubmed |
pubmed-article:14517080 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14517080 | pubmed:language | eng | lld:pubmed |
pubmed-article:14517080 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14517080 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14517080 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14517080 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14517080 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14517080 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14517080 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14517080 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14517080 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14517080 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14517080 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14517080 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14517080 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14517080 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14517080 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14517080 | pubmed:month | Sep | lld:pubmed |
pubmed-article:14517080 | pubmed:issn | 0042-6822 | lld:pubmed |
pubmed-article:14517080 | pubmed:author | pubmed-author:HahnYoung SYS | lld:pubmed |
pubmed-article:14517080 | pubmed:author | pubmed-author:Eisen-Vanderv... | lld:pubmed |
pubmed-article:14517080 | pubmed:author | pubmed-author:YaoZhi... | lld:pubmed |
pubmed-article:14517080 | pubmed:author | pubmed-author:RaySumaS | lld:pubmed |
pubmed-article:14517080 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14517080 | pubmed:day | 15 | lld:pubmed |
pubmed-article:14517080 | pubmed:volume | 314 | lld:pubmed |
pubmed-article:14517080 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14517080 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14517080 | pubmed:pagination | 271-82 | lld:pubmed |
pubmed-article:14517080 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:meshHeading | pubmed-meshheading:14517080... | lld:pubmed |
pubmed-article:14517080 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:14517080 | pubmed:articleTitle | HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1. | lld:pubmed |
pubmed-article:14517080 | pubmed:affiliation | Department of Pathology, Beirne Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA. | lld:pubmed |
pubmed-article:14517080 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14517080 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:14517080 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:1027 | entrezgene:pubmed | pubmed-article:14517080 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:14517080 | lld:entrezgene |
lhgdn:association:4894 | lhgdn:found_in | pubmed-article:14517080 | lld:lhgdn |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14517080 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14517080 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14517080 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14517080 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14517080 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14517080 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14517080 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14517080 | lld:pubmed |